These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9173721)

  • 21. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database).
    Albert NM; Birtcher KK; Cannon CP; Goff DC; Mulgund J; Liang L; Fonarow GC
    Am J Cardiol; 2008 May; 101(9):1242-6. PubMed ID: 18435951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggressive lipid-lowering therapy: a clinical imperative.
    Pedersen TR
    Eur Heart J; 1998 Oct; 19 Suppl M():M15-21. PubMed ID: 9821012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensive lipid-lowering therapy in patients with coronary heart disease.
    Lauderdale SA; Sheehan AH
    Ann Pharmacother; 2005 Feb; 39(2):329-34. PubMed ID: 15613464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Niacin-based therapy for dyslipidemia: past evidence and future advances.
    Ito MK
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S315-22. PubMed ID: 12240703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in drug treatment of dyslipidemia: focus on atorvastatin.
    Davignon J
    Can J Cardiol; 1998 May; 14 Suppl B():28B-38B. PubMed ID: 9627539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
    Kuryata OV; Yegorova YV
    Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study.
    Stone PH; Lloyd-Jones DM; Kinlay S; Frei B; Carlson W; Rubenstein J; Andrews TC; Johnstone M; Sopko G; Cole H; Orav J; Selwyn AP; Creager MA;
    Circulation; 2005 Apr; 111(14):1747-55. PubMed ID: 15809368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of dyslipidemia in primary care.
    Alzahrani T; Marrat S; Haider A
    Can J Cardiol; 2003 Dec; 19(13):1499-502. PubMed ID: 14760440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Undertreatment of hyperlipidemia in patients with coronary artery disease and heart failure.
    Sueta CA; Massing MW; Chowdhury M; Biggs DP; Simpson RJ
    J Card Fail; 2003 Feb; 9(1):36-41. PubMed ID: 12612871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of ciprofibrate on the endothelial dysfunction of patients with combined dyslipidemia].
    Kovács I; Tarján J; Császár A
    Orv Hetil; 2001 Apr; 142(15):775-9. PubMed ID: 11367862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of hyperlipidemia].
    Yoshino G
    Rinsho Byori; 2002 Mar; 50(3):254-61. PubMed ID: 11985052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regression of coronary arteriosclerosis by treatment of disorders of lipid metabolism? Initial clinical results and methodologic problems].
    von Essen R
    Internist (Berl); 1992 Jan; 33(1):62-6. PubMed ID: 1551764
    [No Abstract]   [Full Text] [Related]  

  • 34. Strategy for diagnosis and treatment of hyperlipidemia.
    Erkelens DW
    Ther Umsch; 1990 Jun; 47(6):443-7. PubMed ID: 2197753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lipid-lowering medication--indications and possible hazards. Report from a hearing].
    Aursnes I; Osnes JB; Platou ES; Smiseth OA
    Tidsskr Nor Laegeforen; 1993 Sep; 113(23):2930-2. PubMed ID: 8236199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid-lowering therapy and its effect on atherosclerosis.
    Thompson GR
    Postgrad Med J; 1989; 65 Suppl 1():S22-5. PubMed ID: 2695906
    [No Abstract]   [Full Text] [Related]  

  • 37. Regression of coronary artery disease: the role of plaque biology.
    Valle BK; Valle GA; Lemberg L
    Am J Crit Care; 1995 Nov; 4(6):481-4. PubMed ID: 8556091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lipid-lowering drugs in preventing atherosclerosis].
    Patsch JR
    Internist (Berl); 1989 May; 30(5):309-14. PubMed ID: 2661474
    [No Abstract]   [Full Text] [Related]  

  • 39. Dyslipidemia and coronary artery disease in the elderly.
    LaRosa JC
    Clin Geriatr Med; 1996 Feb; 12(1):33-40. PubMed ID: 8653661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atherosclerosis regression, plaque disruption, and cardiovascular events: a rationale for lipid lowering in coronary artery disease.
    Brown BG; Zhao XQ; Sacco DE; Albers JJ
    Annu Rev Med; 1993; 44():365-76. PubMed ID: 8476257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.